Medicine First “Double blind” clinical results of full-spectrum cannabinoid based medicine..

A phytopharmaceutical future

  • Currently utilizing compounding pharmacy preparations in AU.

  • Pipeline in place for clinical studies to discover future drugs and additional indications.

  • Pipeline in place for clinical studies to discover future drugs and additional indications.

Syqe Air

World’s first metered dose medical inhalation device.

Syqe Medical has completed several successful clinical trials that demonstrated the ability to provide predictable, precise and consistent bioavailability. Unlike traditional inhalers, Syqe’s breakthrough drug delivery technology introduces precision electronic dose control and inspiration automation, ensuring programmable consistent pharmacokinetics.

Pulmonary drug delivery offers several potential clinical advantages. It allows for lower doses of drug to be administered than needed in oral drug delivery, typically leading to a reduction in toxicity and fewer adverse events.

Inhalation can also provide faster onset of action when compared to an oral route of administration.The Syqe device was designed for the administration of pharmaceuticals and medicinal plants which are contained in a unique cartridge.

The cartridge contains VaporChips, pre-loaded with a precise and uniform amount of medicinal material. The inhaler delivers an individually tailored precise dosage for the daily treatment regime of each patient. The inhaler is simple and friendly to use and can be used unobtrusively.

Syqe and Cannabis

The efficacy of treatment with medical cannabis using a Syqe Inhaler has been demonstrated in several clinical trials.

The findings of these studies indicate that the Syqe Inhaler provides measured, uniform doses, and is safe and efficient for the treatment of chronic pain.

It has also been found that the delivery of cannabis using the inhaler reduces the psychoactive effects, by providing precise efficacious low doses of ∆9-THC (the main psychoactive component of cannabis) measured in micrograms.

In addition to its clinical advantages, the Syqe Inhaler has been found to be convenient and beneficial for both patients and physicians, who can control the treatment in unprecedented precision, enabling continuous robust clinical follow-up.

The cannabis plant contains multiple different compounds. To date, many such compounds have been identified, some of which are known to be involved in the beneficial clinical effects of the plant.

The therapeutic value of the combination of compounds has been shown to have a greater effect than isolated molecules for specific health conditions, which is the motivating force for Syqe Medical’s use of whole cannabis flowers in lieu of isolated compounds.

Whole cannabis flowers are milled in a unique process that preserves the plant’s medicinal properties, nothing else is added or changed. The cannabis granulate is precisely dispensed into VaporChips, and then loaded into cartridges. The Inhaler then generates from each VaporChip a selective-dose aerosol meeting pharmaceutical standards.

Syqe Medical uses only cannabis produced under controlled pharmaceutical standards, from the planting stage through its administration via the Syqe Inhaler.

About eCS Clinic

eCS Clinic provides personalized support for patients suffering the various symptoms related to Chronic Endocannabinoid Deficiency Syndrome (CEDS). Our vision is to create the world’s leading ECS community through with research, education and evidence-based treatment.

CEDS is a new discovery. eCS Clinic’s doctors and nurses are specialised in CEDS: diagnosis and treatment.

What is the ECS and CEDS

The endocannabinoid system (ECS) is a messaging system in your body (a series of chemical transmitters and receptors) that modulate just about every physiological function in your body. The ECS:

  • regulates pain and inflammation pathways – in your joints and organs
  • effects how you sleep and how you feel (emotions)
  • regulates your appetite and metabolism
  • effects your memory and thinking (cognition)
  • regulate gastro-intestinal / gut function
  • regulates the protection and development of nerves in your body

For different reasons, such as lifestyle triggers or genetic factors, the ECS system can be under-functioning in many people, and this results in symptoms that often take years to develop. This is now known as Clinical Endocannabinoid Deficiency Syndrome (CEDS).Symptoms of CEDS may include:

  • Anxiety and Depression
  • Migraines and Headaches
  • Gastro-intestinal and metabolism dysfunction
  • Nerve vulnerability and deterioration
  • Pain, Inflammation and Fibromyalgia
  • Memory, thinking and cognition problems
  • Insomnia and other sleep issues
  • Repetitive failed treatment

Real Help from Real People

eCS Clinic’s doctors and nurses are specialised in Chronic Endocannabinoid Deficiency Syndrome (CEDS): diagnosis and treatment. CEDS is a new discovery and most practitioners did not learn about it in their training. Your treatment is personalised and unique to you, CEDS can present in a broad symptomatology and each person will react in a unique way. Our practitioners take time with each patient, providing in-depth consultations to properly understand your unique situation.

Chronic Endocannabinoid Deficiency Syndrome or CEDS, incorporates a range of chronic symptoms related to the under-functioning of the endocannabinoid system (ECS).

At eCS Clinic, we offer an integrated approach to patients presenting with CEDS, through a biopsychosocial model and our multidisciplinary CEDS specialists.

Each patient is different, and we strongly believe in a personalised approach unique to each. Our CEDS program includes:

Medicine Regimen

Prescribed endocannabinoids and phytocannabinoids are some of the most effective treatments to rebalance the ECS.

Exercise programs

Exercise will always match your comfort level and abilities, it has shown to boost and rebalance ECS functioning.

Psychological Support

Psychology deals with a large part of CEDS through neurophysiological treatment.

Referrals as required

We at eCS Clinic know that CEDS treatment may only be a part of the puzzle. Our team collaborates closely with each patient’s care team to ensure optimal treatment outcomes.

“So many come to the sickroom thinking of themselves as men of science fighting disease and not as healers with a little knowledge helping nature to get a sick man well.”

– Sir Auckland Geddes

Medical Focus

Kensana Key

  • CANNect® has demonstrated significant early chronic pain market penetration due to a carefully crafted value proposition aligned with key prescriber and patient needs.

  • CANNect platform facilitates scalable patient monitoring and data collection as well as assists doctors to navigate confusing clinical and regulatory process.

  • Strong connection and roll out pilots with two major GP groups as well as a significant referral base from specific areas of speciality medicine.

  • Commenced the development of a Medical Canna-binoid online education and CPD program for Doctors.

  • The CANNect Platform collects outcome data from patients allowing real world experience (RWE) to improve individual patient results, and further our understanding in the field.

Syqe Medical

  • Medical grade inhaler

  • Cannabinoids & other medicinal plants.

  • Dosing Precision & Efficiency.

  • The lowest inter-individual variability of THC plasma concentration.

Phyto Micro-Encapsulation

  • Developing a phyto micro-encapsulation technology in partnership with Cannasoul.

  • Benefits include: Dispersibility, Physical and Chemical stability, Taste masking properties.

  • Can be used with standardized phyto-substances to produce liquid medicinals in many forms.